Semaglutide is gaining traction as a novel treatment for insulin resistance. This engineered glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to release more insulin and reducing https://sairajtwd134659.blog-ezine.com/35873561/comprehending-semaglutide-a-comprehensive-guide